LIF vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

LIF

33.6
AI Score
VS
PACS Wins

PACS

41.3
AI Score

Investment Advisor Scores

LIF

34score
Recommendation
SELL

PACS

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LIF PACS Winner
Revenue 476.22M 4.35B PACS
Net Income 30.33M 217.88M PACS
Net Margin 6.4% 5.0% LIF
Operating Income -164,000 329.09M PACS
ROE 4.8% 17.9% PACS
ROA 2.8% 3.7% PACS
Total Assets 1.09B 5.92B PACS
Cash 333.14M 115.28M LIF
Current Ratio 5.31 0.80 LIF

Relative Price Performance (Last 90 Days)

LIF 1M: +5.0% · 3M: -11.1% PACS 1M: +12.8% · 3M: +11.3%

Current Technical Phase

LIF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.5 · Price: $44.66

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 60

RSI (14): 60.5 · Price: $50.06

Fundamentals Snapshot

Metric LIF PACS
Market Cap — —
Forward P/E 24.8 17.6
Trailing P/E 24.4 27.7
Revenue (TTM) — —
Revenue Growth 0.4% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin 0.0% 0.1%
EPS 1.72 1.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.